|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2000-1-18
|
|
pubmed:abstractText |
To evaluate the incidence of clinically relevant cardiac toxicity after treatment with epirubicin/paclitaxel-containing regimens in patients with metastatic breast cancer and to identify high-risk patients in whom the benefit of chemotherapy may be negated by the occurrence of congestive heart failure (CHF).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3596-602
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10550159-Adult,
pubmed-meshheading:10550159-Aged,
pubmed-meshheading:10550159-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10550159-Breast Neoplasms,
pubmed-meshheading:10550159-Echocardiography,
pubmed-meshheading:10550159-Epirubicin,
pubmed-meshheading:10550159-Female,
pubmed-meshheading:10550159-Heart Failure,
pubmed-meshheading:10550159-Humans,
pubmed-meshheading:10550159-Life Tables,
pubmed-meshheading:10550159-Middle Aged,
pubmed-meshheading:10550159-Paclitaxel,
pubmed-meshheading:10550159-Risk Factors,
pubmed-meshheading:10550159-Ventricular Function, Left
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors.
|
|
pubmed:affiliation |
Divisione di Oncologia Medica, Dipartimento di Oncologia, Ospedale Santa Chiara e Universita, Pisa, Italy. a.gennari@do.med.unipi.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
